|72.70|| +0.50 / +0.69%|
Novartis AG develops, manufactures, and markets healthcare products. It operates through the following segments: Pharmaceuticals, Alcon, Sandoz, Vaccines & Diagnostics, and Consumer Health. The Pharmaceuticals segment provides patent-protected prescription medicines. The Alcon segment offers surgical, ophthalmic pharmaceuticals, and vision care products. The Sandoz segment provides generic pharmaceuticals. The Vaccines & Diagnostics segment provides human vaccines and blood testing diagnostics. The Consumer Health segment operates two divisions: Over-the-Counter (OTC) and Animal Health. The OTC division develops and sells a wide range of affordable and reliable consumer medications for self-care and numerous common ailments. The Animal Health division's products prolong and improve animals lives. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.
|Joseph Jimenez||Chief Executive Officer|
|Harry Kirsch||Chief Financial Officer|
|Vasant Narasimhan||Chief Medical Officer & Head-Drug Development|
|Eric Cornut||Chief Ethics, Compliance & Policy Officer|
|Jürgen Brokatzky-Geiger||Global Head-Corporate Responsibility|